Macrophages engulfing apoptotic cells produce nonclassical retinoids to enhance their phagocytic capacity

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5730-5738

  Sarang, Zsolt ^a   Joo's, Gergely ^a   Garabuczi, Éva ^a   Rühl, Ralph ^b   Gregory, Christopher D ^c   Szondy, Zsuzsa ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; LIVER X RECEPTOR; MER TYROSINE KINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN TYROSINE KINASE; RETINAL DEHYDROGENASE; RETINOID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PHAGOCYTOSIS; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; MACROPHAGE; MACROPHAGE FUNCTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; ATP BINDING CASSETTE TRANSPORTER 1; GTP-BINDING PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; PHAGOCYTOSIS; RETINOIDS; TRANSGLUTAMINASES;

EID: 84902195829     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400284     Document Type: Article

References (53)

1. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-975.
2. Stuart, L. M., and R. A. Ezekowitz. 2005. Phagocytosis: elegant complexity. Immunity 22:539-550.
3. Ravichandran, K. S., and U. Lorenz. 2007. Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 7:964-974.
4. Fadok, V. A., and P. M. Henson. 2003. Apoptosis: giving phosphatidylserine recognition an assist-with a twist. Curr. Biol. 13:R655-R657.
5. Hanayama, R., M. Tanaka, K. Miwa, A. Shinohara, A. Iwamatsu, and S. Nagata. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182-187.
6. Savill, J. S., N. Hogg, Y. Ren, and C. Haslett. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-1522.
7. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
8. -/- mice. J. Cell Biol. 167:1161-1170.
9. Park, D., A. Hochreiter-Hufford, and K. S. Ravichandran. 2009. The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr. Biol. 19:346-351.
10. Greenberg, M. E., M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S. L. Hazen. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203:2613-2625.
11. Albert, M. L., J. I. Kim, and R. B. Birge. 2000. alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nat. Cell Biol. 2:899-905.
12. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196:135-140.
13. Park, S. Y., M. Y. Jung, H. J. Kim, S. J. Lee, S. Y. Kim, B. H. Lee, T. H. Kwon, R. W. Park, and I. S. Kim. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15:192-201.
14. Hamon, Y., D. Trompier, Z. Ma, V. Venegas, M. Pophillat, V. Mignotte, Z. Zhou, and G. Chimini. 2006. Cooperation between engulfment receptors: the case of ABCA1 and MEGF10. PLoS ONE 1:e120.
15. Kinchen, J. M., J. Cabello, D. Klingele, K. Wong, R. Feichtinger, H. Schnabel, R. Schnabel, and M. O. Hengartner. 2005. Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature 434:93-99.
16. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Díaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245-258.
17. Roszer, T., M. P. Menéndez-Gutiérrez, M. I. Lefterova, D. Alameda, V. Núñez, M. A. Lazar, T. Fischer, and M. Ricote. 2011. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J. Immunol. 186:621-631.
18. Mukundan, L., J. I. Odegaard, C. R. Morel, J. E. Heredia, J. W. Mwangi, R. R. Ricardo-Gonzalez, Y. P. Goh, A. R. Eagle, S. E. Dunn, J. U. Awakuni, et al. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med. 15:1266-1272.
19. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
20. Heyman, R. A., D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406.
21. Rühl, R. 2006. Method to determine 4-oxo-retinoic acids, retinoic acids and retinol in serum and cell extracts by liquid chromatography/diode- array detection atmospheric pressure chemical ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20:2497-2504.
22. Kam, R. K., Y. Deng, Y. Chen, and H. Zhao. 2012. Retinoic acid synthesis and functions in early embryonic development. Cell Biosci. 2:11.
23. Germain, P., P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer. 2006. International union of pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 58:760-772.
24. Calkin, A. C., and P. Tontonoz. 2012. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13:213-224.
25. Yoshikawa, T., H. Shimano, M. Amemiya-Kudo, N. Yahagi, A. H. Hasty, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, et al. 2001. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 21:2991-3000.
26. Rébé, C., M. Raveneau, A. Chevriaux, D. Lakomy, A. L. Sberna, A. Costa, G. Bessède, A. Athias, E. Steinmetz, J. M. Lobaccaro, et al. 2009. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages. Circ. Res. 105:393-401.
27. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275:28240-28245.
28. Li, Y., C. Bolten, B. G. Bhat, J. Woodring-Dietz, S. Li, S. K. Prayaga, C. Xia, and D. S. Lala. 2002. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism. Mol. Endocrinol. 16:506-514.
29. Tóth, B., E. Garabuczi, Z. Sarang, G. Vereb, G. Vámosi, D. Aeschlimann, B. Blaskó, B. Bécsi, F. Erdõdi, A. Lacy-Hulbert, et al. 2009. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J. Immunol. 182:2084-2092.
30. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. USA 100:7812-7817.
31. Tanaka, M., and Y. Miyake. 2007. Apoptotic cell clearance and autoimmune disorder. Curr. Med. Chem. 14:2892-2897.
32. Rossant, J., R. Zirngibl, D. Cado, M. Shago, and V. Giguère. 1991. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev. 5:1333-1344.
33. Aydemir, G., Y. Kasiri, E. Birta, G. Béke, A. L. Garcia, E. M. Bartók, and R. Rühl. 2013. Lycopene-derived bioactive retinoic acid receptors/retinoid-X receptors-activating metabolites may be relevant for lycopene's anti-cancer potential. Mol. Nutr. Food Res. 57:739-747.
34. Moore, W. T., Jr., M. P. Murtaugh, and P. J. Davies. 1984. Retinoic acid-induced expression of tissue transglutaminase in mouse peritoneal macrophages. J. Biol. Chem. 259:12794-12802.
35. Bayardo, M., F. Punzi, C. Bondar, N. Chopita, and F. Chirdo. 2012. Transglutaminase 2 expression is enhanced synergistically by interferon-g and tumour necrosis factor-a in human small intestine. Clin. Exp. Immunol. 168:95-104.
36. Garabuczi, E., B. Kiss, S. Felszeghy, G. J. Tsay, L. Fésüs, and Z. Szondy. 2013. Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes. Amino Acids 44:235-244.
37. Huq, M. D., N. P. Tsai, P. Gupta, and L. N. Wei. 2006. Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolites. EMBO J. 25:3203-3213.
38. Szondy, Z., P. Molnar, Z. Nemes, M. Boyiadzis, N. Kedei, R. Tóth, and L. Fésüs. 1997. Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways. FEBS Lett. 404:307-313.
39. Kiss, I., R. Rühl, E. Szegezdi, B. Fritzsche, B. Tóth, J. Pongrácz, T. Perlmann, L. Fésüs, and Z. Szondy. 2008. Retinoid receptor-activating ligands are produced within the mouse thymus during postnatal development. Eur. J. Immunol. 38:147-155.
40. Moise, A. R., V. Kuksa, Y. Imanishi, and K. Palczewski. 2004. Identification of all-trans-retinol: all-trans-13, 14-dihydroretinol saturase. J. Biol. Chem. 279:50230-50242.
41. Moise, A. R., V. Kuksa, W. S. Blaner, W. Baehr, and K. Palczewski. 2005. Metabolism and transactivation activity of 13, 14-dihydroretinoic acid. J. Biol. Chem. 280:27815-27825.
42. Moise, A. R., S. Alvarez, M. Domínguez, R. Alvarez, M. Golczak, G. P. Lobo, J. Von Lintig, A. R. De Lera, and K. Palczewski. 2009. Activation of retinoic acid receptors by dihydroretinoids. Mol. Pharmacol. 76:1228-1237.
43. Sarang, Z., E. Garabuczi, G. Joós, B. Kiss, K. Tóth, R. Rühl, and Z. Szondy. 2013. Macrophages engulfing apoptotic thymocytes produce retinoids to promote selection, differentiation, removal and replacement of double positive thymocytes. Immunobiology 218:1354-1360.
44. Soroosh, P., T. A. Doherty, W. Duan, A. K. Mehta, H. Choi, Y. F. Adams, Z. Mikulski, N. Khorram, P. Rosenthal, D. H. Broide, and M. Croft. 2013. Lungresident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 210:775-788.
45. Moise, A. R., G. P. Lobo, B. Erokwu, D. L. Wilson, D. Peck, S. Alvarez, M. Domínguez, R. Alvarez, C. A. Flask, A. R. De Lera, et al. 2010. Increased adiposity in the retinol saturase-knockout mouse. FASEB J. 24:1261-1270.
46. Licht, R., J. W. Dieker, C. W. Jacobs, W. J. Tax, and J. H. Berden. 2004. Decreased phagocytosis of apoptotic cells in diseased SLE mice. J. Autoimmun. 22:139-145.
47. Gaipl, U. S., L. E. Munoz, G. Grossmayer, K. Lauber, S. Franz, K. Sarter, R. E. Voll, T. Winkler, A. Kuhn, J. Kalden, et al. 2007. Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun. 28:114-121.
48. McColl, A., S. Bournazos, S. Franz, M. Perretti, B. P. Morgan, C. Haslett, and I. Dransfield. 2009. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J. Immunol. 183:2167-2175.
49. Walsh, S. J., C. Algert, D. I. Gregorio, S. T. Reisine, and N. F. Rothfield. 1995. Divergent racial trends in mortality from systemic lupus erythematosus. J. Rheumatol. 22:1663-1668.
50. Kinoshita, K., B. S. Yoo, Y. Nozaki, M. Sugiyama, S. Ikoma, M. Ohno, M. Funauchi, and A. Kanamaru. 2003. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J. Immunol. 170:5793-5798.
51. Pérez De Lema, G., F. J. Lucio-Cazaña, A. Molina, B. Luckow, H. Schmid, C. De Wit, V. Moreno-Manzano, B. Banas, F. Mampaso, and D. Schlöndorff. 2004. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int. 66:1018-1028.
52. Kinoshita, K., K. Kishimoto, H. Shimazu, Y. Nozaki, M. Sugiyama, S. Ikoma, and M. Funauchi. 2010. Successful treatment with retinoids in patients with lupus nephritis. Am. J. Kidney Dis. 55:344-347.
53. Carratù, M. R., C. Marasco, G. Mangialardi, and A. Vacca. 2012. Retinoids: novel immunomodulators and tumour-suppressive agents? Br. J. Pharmacol. 167:483-492